MRVI vs. EQQQ.L
Compare and contrast key facts about Maravai LifeSciences Holdings, Inc. (MRVI) and Invesco EQQQ NASDAQ-100 UCITS ETF (EQQQ.L).
EQQQ.L is a passively managed fund by Invesco that tracks the performance of the NASDAQ-100 Index. It was launched on Dec 2, 2002.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRVI or EQQQ.L.
Correlation
The correlation between MRVI and EQQQ.L is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MRVI vs. EQQQ.L - Performance Comparison
Key characteristics
MRVI:
-0.18
EQQQ.L:
1.46
MRVI:
0.44
EQQQ.L:
2.01
MRVI:
1.06
EQQQ.L:
1.27
MRVI:
-0.20
EQQQ.L:
1.98
MRVI:
-0.54
EQQQ.L:
5.93
MRVI:
33.62%
EQQQ.L:
4.07%
MRVI:
100.26%
EQQQ.L:
16.47%
MRVI:
-93.20%
EQQQ.L:
-33.75%
MRVI:
-93.07%
EQQQ.L:
-1.65%
Returns By Period
In the year-to-date period, MRVI achieves a -22.94% return, which is significantly lower than EQQQ.L's 2.95% return.
MRVI
-22.94%
-11.95%
-56.61%
-20.90%
N/A
N/A
EQQQ.L
2.95%
-0.56%
16.21%
24.15%
19.38%
20.48%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRVI vs. EQQQ.L — Risk-Adjusted Performance Rank
MRVI
EQQQ.L
MRVI vs. EQQQ.L - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Maravai LifeSciences Holdings, Inc. (MRVI) and Invesco EQQQ NASDAQ-100 UCITS ETF (EQQQ.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MRVI vs. EQQQ.L - Dividend Comparison
MRVI has not paid dividends to shareholders, while EQQQ.L's dividend yield for the trailing twelve months is around 0.37%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRVI Maravai LifeSciences Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EQQQ.L Invesco EQQQ NASDAQ-100 UCITS ETF | 0.37% | 0.38% | 0.39% | 0.56% | 0.25% | 0.41% | 0.56% | 0.63% | 0.67% | 0.77% | 0.72% | 1.01% |
Drawdowns
MRVI vs. EQQQ.L - Drawdown Comparison
The maximum MRVI drawdown since its inception was -93.20%, which is greater than EQQQ.L's maximum drawdown of -33.75%. Use the drawdown chart below to compare losses from any high point for MRVI and EQQQ.L. For additional features, visit the drawdowns tool.
Volatility
MRVI vs. EQQQ.L - Volatility Comparison
Maravai LifeSciences Holdings, Inc. (MRVI) has a higher volatility of 19.61% compared to Invesco EQQQ NASDAQ-100 UCITS ETF (EQQQ.L) at 5.39%. This indicates that MRVI's price experiences larger fluctuations and is considered to be riskier than EQQQ.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.